Medical Physics Seminar

Approximately 50% of head and neck cancer patients will experience locoregional disease recurrence following initial courses of therapy which commonly includes primary or secondary external beam radiation therapy. This talk will highlight the application of this workflow supporting a phase I clinical trial in humans investigating the efficacy of combining EBRT and a radio-iodinated (Iodine-131) alkylphosphocholine analog for treating relapsed HNC with curative intent.